These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6111218)
41. Authors' response to letter regarding the WA regulatory scheme for stimulants. Calver J; Sanfilippo F; Preen D; Bulsara M Aust N Z J Public Health; 2008 Aug; 32(4):395. PubMed ID: 18782409 [No Abstract] [Full Text] [Related]
42. CNS stimulants and the look-alike drugs. Lake CR; Quirk RS Psychiatr Clin North Am; 1984 Dec; 7(4):689-701. PubMed ID: 6151645 [TBL] [Abstract][Full Text] [Related]
43. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Degenhardt L; Baker A; Maher L Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601 [No Abstract] [Full Text] [Related]
44. [Drug interference of drugs affecting the central nervous system. 2: drug interactions of stimulants]. Estler CJ Fortschr Med; 1983 Nov; 101(41):1869-72 contd. PubMed ID: 6654286 [No Abstract] [Full Text] [Related]
46. Adderall: the newest available option in ADHD. Adv Nurse Pract; 1997 Jun; 5(6):73-4. PubMed ID: 9459934 [No Abstract] [Full Text] [Related]
47. [Effect of psychic stimulants on the temporal parameters of visual perception]. Barkov NK; Machula AI Farmakol Toksikol; 1981; 44(1):12-4. PubMed ID: 6114877 [No Abstract] [Full Text] [Related]
48. Perceptions about behind-the-counter availability of pseudoephedrine. Shi CW; Ganiats TG Am J Health Syst Pharm; 2007 Feb; 64(3):236-7. PubMed ID: 17244867 [No Abstract] [Full Text] [Related]
49. Clandestine drug synthesis. Soine WH Med Res Rev; 1986; 6(1):41-74. PubMed ID: 3512935 [No Abstract] [Full Text] [Related]
50. A note on the synergism of the central nervous system stimulants. AHLQUIST RP J Am Pharm Assoc Am Pharm Assoc; 1947 Dec; 36(12):414. PubMed ID: 18917443 [No Abstract] [Full Text] [Related]
51. Bulk and prescription drugs. Hoffsis GF J Am Vet Med Assoc; 1985 Sep; 187(6):578-81. PubMed ID: 4086364 [No Abstract] [Full Text] [Related]
52. [Relations between function and metabolism of the central nervous system after pervitin administration]. HEIM F; LEUSCHNER F; ESTLER KJ Experientia; 1957 Nov; 13(11):462-4. PubMed ID: 13501230 [No Abstract] [Full Text] [Related]
53. The use of therapeutics in adolescence. Hein K J Adolesc Health Care; 1987 Jan; 8(1):8-35. PubMed ID: 3546228 [No Abstract] [Full Text] [Related]
54. Pharmacoterrorism: We should be worried. Khanra S; Sen S Asian J Psychiatr; 2016 Aug; 22():83. PubMed ID: 27520902 [No Abstract] [Full Text] [Related]
55. Drugs purchased abroad--caution to travelers. Med Lett Drugs Ther; 1973 May; 15(11):48. PubMed ID: 4712980 [No Abstract] [Full Text] [Related]
56. Stimulants and other drugs of abuse and their effects on neuropeptides and the peptidergic systems. Proceedings of a symposium. Marco Island, Florida, USA. June 28-29, 2002. Life Sci; 2003 Jun; 73(6):641-822. PubMed ID: 12801585 [No Abstract] [Full Text] [Related]
57. The central stimulant action of some commercial nose drop preparations. McPHAIL MK Laryngoscope; 1949 Mar; 59(3):278-86. PubMed ID: 18118206 [No Abstract] [Full Text] [Related]
58. [Knockout Drugs: Diagnostics in the Emergency Unit and Clinical Practice]. Bühler T; Schmid Y; Liechti ME Praxis (Bern 1994); 2019 Sep; 108(13):869-876. PubMed ID: 31571536 [TBL] [Abstract][Full Text] [Related]
59. Taljaribu kila dawa isifal: yohimbine intoxication. Mack RB N C Med J; 1985 Apr; 46(4):229-30. PubMed ID: 3857471 [No Abstract] [Full Text] [Related]